Angeles Wealth Management LLC Purchases 5,583 Shares of Cigna Group $CI

Angeles Wealth Management LLC grew its position in shares of Cigna Group (NYSE:CIFree Report) by 233.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,972 shares of the health services provider’s stock after buying an additional 5,583 shares during the period. Angeles Wealth Management LLC’s holdings in Cigna Group were worth $2,298,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CI. Brighton Jones LLC increased its stake in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares in the last quarter. Sivia Capital Partners LLC lifted its stake in shares of Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after buying an additional 109 shares in the last quarter. Crestwood Advisors Group LLC boosted its holdings in Cigna Group by 14.5% in the 2nd quarter. Crestwood Advisors Group LLC now owns 1,743 shares of the health services provider’s stock worth $576,000 after buying an additional 221 shares during the period. Atlantic Union Bankshares Corp bought a new position in Cigna Group in the 2nd quarter worth approximately $3,118,000. Finally, Resona Asset Management Co. Ltd. grew its stake in Cigna Group by 0.6% in the 2nd quarter. Resona Asset Management Co. Ltd. now owns 95,671 shares of the health services provider’s stock valued at $31,565,000 after buying an additional 609 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the topic of several recent research reports. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Piper Sandler reduced their target price on Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday. Deutsche Bank Aktiengesellschaft increased their price target on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. Robert W. Baird reduced their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research note on Thursday, December 11th. Finally, Truist Financial upped their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $330.42.

Read Our Latest Research Report on Cigna Group

Cigna Group Stock Down 3.5%

Shares of CI opened at $271.50 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. The stock has a 50 day simple moving average of $280.71 and a two-hundred day simple moving average of $284.24. The firm has a market cap of $71.55 billion, a P/E ratio of 12.24, a P/E/G ratio of 0.97 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a $1.56 dividend. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.